Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study

Journal of Urology

Volumn 186, Issue 4, 2011, Pages 1313-1318

  Nickel, J Curtis ^a   Roehrborn, Claus ^b   Montorsi, Francesco ^c   Wilson, Timothy H ^d   Rittmaster, Roger S ^d  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d GLAXOSMITHKLINE   (United States)

Author keywords

5 alpha reductase inhibitors; dutasteride; prostatitis

Indexed keywords

DUTASTERIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; CHRONIC PROSTATITIS SYMPTOM INDEX; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; PROSTATITIS LIKE PAIN; PROSTATITIS LIKE SYNDROME; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SYMPTOM;

5-ALPHA REDUCTASE INHIBITORS; AGED; AZASTEROIDS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSTATITIS;

EID: 80052767337     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.05.071     Document Type: Article

References (30)

1. M.A. Pontari, and M.R. Ruggieri Mechanisms in prostatitis/chronic pelvic pain syndrome J Urol 172 2004 839
2. D.A. Shoskes, J.C. Nickel, and R. Dolinga Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity Urology 73 2009 538
3. A.J. Schaeffer Clinical practice Chronic prostatitis and the chronic pelvic pain syndrome N Engl J Med 355 2006 1690
4. J.C. Nickel Treatment of chronic prostatitis/chronic pelvic pain syndrome P. Dahm, R.R. Dmochowski, Evidence-Based Urology 2nd ed. 2010 Wiley-Blackwell Chichester, UK 111 116
5. J.C. Nickel Role of alpha1-blockers in chronic prostatitis syndromes BJU Int 101 2008 11
6. R.B. Alexander, K.J. Propert, and A.J. Schaeffer Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial Ann Intern Med 141 2004 581
7. J.C. Nickel, J.N. Krieger, and M. McNaughton-Collins Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome N Engl J Med 359 2008 2663
8. C.G. Roehrborn, P. Siami, and J. Barkin The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study Eur Urol 57 2010 123
9. G.L. Andriole, D.G. Bostwick, and O.W. Brawley Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 2010 1192
10. J.C. Nickel 5-α-Reductase therapy for chronic prostatitis Textbook of Prostatitis 1999 ISIS Medical Media Oxford, UK 333 338
11. M. Holm, and H.H. Meyhoff Chronic prostatic pain A new treatment option with finasteride? Scand J Urol Nephrol 31 1997 213
12. M. Leskinen, O. Lukkarinen, and T. Marttila Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study Urology 53 1999 502
13. G. Andriole, D. Bostwick, and O. Brawley Chemoprevention of prostate cancer in men at high risk: rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial J Urol 172 2004 1314
14. R.O. Roberts, M.M. Lieber, and T. Rhodes Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men Urology 51 1998 578
15. M.A. Pontari Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment Drugs Aging 20 2003 1111
16. J.C. Nickel, C.G. Roehrborn, and M.P. O'Leary Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial J Urol 178 2007 896
17. M.S. Litwin, M. McNaughton-Collins, and F.J. Fowler Jr The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure Chronic Prostatitis Collaborative Research Network J Urol 162 1999 369
18. K.J. Propert, M.S. Litwin, and Y. Wang Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Qual Life Res 15 2006 299
19. M.A. Pontari, J.N. Krieger, and M.S. Litwin Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial Arch Intern Med 170 2010 1586
20. J.C. Nickel, J. Downey, and D. Hunter Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index J Urol 165 2001 842
21. J.Q. Clemens, R.T. Meenan, and M.C. O'Keeffe-Rosetti Prevalence of prostatitis-like symptoms in a managed care population J Urol 176 2006 593
22. J.C. Hu, C.L. Link, and M. McNaughton-Collins The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey J Gen Intern Med 22 2007 1532
23. D.A. Shoskes, J.R. Landis, and Y. Wang Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome J Urol 172 2004 542
24. J.C. Nickel, J. Downey, and M.A. Pontari A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis) BJU Int 93 2004 991
25. J.C. Nickel The role of the animal model in the study of prostatitis T. Bergan, Infectiology: Urinary Tract Infections 1997 S Karger AG Basel, Switzerland 89 97
26. R.S. Kirby, D. Lowe, and M.I. Bultitude Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis Br J Urol 54 1982 729
27. S.A. Kaplan, E.F. Ikeguchi, and R.P. Santarosa Etiology of voiding dysfunction in men less than 50 years of age Urology 47 1996 836
28. A. Mehik, P. Hellstrom, and J.C. Nickel The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements J Urol 167 2002 137
29. S.A. Kaplan, M.A. Volpe, and A.E. Te A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome J Urol 171 2004 284
30. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215